SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-016342
Filing Date
2021-07-02
Accepted
2021-07-02 16:06:30
Documents
9
Period of Report
2021-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20210701_8k.htm 8-K 32988
2 EXHIBIT 1.1 ex_261470.htm EX-1.1 222156
3 EXHIBIT 5.1 ex_261471.htm EX-5.1 15177
4 EXHIBIT 99.1 ex_261472.htm EX-99.1 12209
5 EXHIBIT 99.2 ex_261473.htm EX-99.2 12280
6 EXHIBIT 99.3 ex_261628.htm EX-99.3 11002
7 a4.jpg GRAPHIC 12558
8 p1.jpg GRAPHIC 9547
9 pt01.jpg GRAPHIC 6847
  Complete submission text file 0001437749-21-016342.txt   347421
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 211069996
SIC: 2834 Pharmaceutical Preparations